搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Haemophilus somnus UPF0133 protein HS_1309 (HS_1309) CSB-YP607936HAAD
CSB-EP607936HAAD
CSB-BP607936HAAD
CSB-MP607936HAAD
CSB-EP607936HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Elongation factor P (efp) CSB-YP607937HAAD
CSB-EP607937HAAD
CSB-BP607937HAAD
CSB-MP607937HAAD
CSB-EP607937HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus tRNA pseudouridine synthase A (truA) CSB-YP607938HAAD
CSB-EP607938HAAD
CSB-BP607938HAAD
CSB-MP607938HAAD
CSB-EP607938HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Chaperone protein TorD (torD) CSB-YP607939HAAD
CSB-EP607939HAAD
CSB-BP607939HAAD
CSB-MP607939HAAD
CSB-EP607939HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Protein SlyX homolog (slyX) CSB-YP607940HAAD
CSB-EP607940HAAD
CSB-BP607940HAAD
CSB-MP607940HAAD
CSB-EP607940HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Diaminopimelate epimerase (dapF) CSB-YP607941HAAD
CSB-EP607941HAAD
CSB-BP607941HAAD
CSB-MP607941HAAD
CSB-EP607941HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP607942HAAD
CSB-EP607942HAAD
CSB-BP607942HAAD
CSB-MP607942HAAD
CSB-EP607942HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus ATP-dependent protease subunit HslV (hslV) CSB-YP607943HAAD
CSB-EP607943HAAD
CSB-BP607943HAAD
CSB-MP607943HAAD
CSB-EP607943HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Cell division protein FtsB (ftsB), partial CSB-YP607944HAAD
CSB-EP607944HAAD
CSB-BP607944HAAD
CSB-MP607944HAAD
CSB-EP607944HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Guanylate kinase (gmk) CSB-YP607945HAAD
CSB-EP607945HAAD
CSB-BP607945HAAD
CSB-MP607945HAAD
CSB-EP607945HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP607946HAAD
CSB-EP607946HAAD
CSB-BP607946HAAD
CSB-MP607946HAAD
CSB-EP607946HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus ATP synthase epsilon chain (atpC) CSB-YP607947HAAD
CSB-EP607947HAAD
CSB-BP607947HAAD
CSB-MP607947HAAD
CSB-EP607947HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus somnus tRNA-specific 2-thiouridylase mnmA (mnmA) CSB-YP607948HAAD
CSB-EP607948HAAD
CSB-BP607948HAAD
CSB-MP607948HAAD
CSB-EP607948HAAD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 30S ribosomal protein S6 (rpsF) CSB-YP607949SAAP
CSB-EP607949SAAP
CSB-BP607949SAAP
CSB-MP607949SAAP
CSB-EP607949SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Urease subunit gamma (ureA) CSB-YP607950SAAP
CSB-EP607950SAAP
CSB-BP607950SAAP
CSB-MP607950SAAP
CSB-EP607950SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. 50S ribosomal protein L9 (rplI) CSB-YP607951SAAP
CSB-EP607951SAAP
CSB-BP607951SAAP
CSB-MP607951SAAP
CSB-EP607951SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase (murG) CSB-YP607952SAAP
CSB-EP607952SAAP
CSB-BP607952SAAP
CSB-MP607952SAAP
CSB-EP607952SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. NAD (P)H-quinone oxidoreductase subunit 1 (ndhA), partial CSB-YP607953SAAP
CSB-EP607953SAAP
CSB-BP607953SAAP
CSB-MP607953SAAP
CSB-EP607953SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Photosystem II 12 kDa extrinsic protein (psbU) CSB-YP607954SAAP
CSB-EP607954SAAP
CSB-BP607954SAAP
CSB-MP607954SAAP
CSB-EP607954SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Synechococcus sp. Anhydro-N-acetylmuramic acid kinase (anmK) CSB-YP607955SAAP
CSB-EP607955SAAP
CSB-BP607955SAAP
CSB-MP607955SAAP
CSB-EP607955SAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>